Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

News

Novo Nordisk slashes price of Ozempic

Digest more
 · 2d · on MSN
US patients can now get Ozempic for half price if they can pay cash
Novo Nordisk announced Monday that US patients can now get a month’s supply of Ozempic, the blockbuster diabetes drug, for $499, for those who pay for medications on their own and don’t go through insurance.

Continue reading

 · 2d · on MSN
Novo Nordisk offers Ozempic at $499 per month to eligible US cash-paying customers
 · 2d · on MSN
Novo Nordisk slashes price of Ozempic in half to $499 for cash-paying, eligible U.S. patients
2d

GLP-1 drug Ozempic is now half the price for patients – on one condition

(CNN) - Patients in the United States can now get the popular diabetes and weight loss drug Ozempic for half the price. Novo ...
Explícame on MSN2d

Novo Nordisk announces significant price cut for its most coveted diabetes drug

Novo Nordisk launches a new cash-pay option for a leading diabetes drug, changing affordability dynamics for uninsured ...
2don MSN

Ozempic price slashed following Donald Trump's demands - will it impact the UK cost?

In the UK, patients can buy a four-week supply of Ozempic for between £119 and £190 from online pharmacies. Novo Nordisk said ...
14d

How Ozempic’s Maker Lost Its Shine After Creating a Wonder Drug

The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy